Ads
related to: baird
Search results
HEICO stock upgraded by Baird on strong 2Q24 results By Investing.com
Investing.com· 10 hours agoThursday saw Baird maintain an Outperform rating on HEICO Corporation (NYSE:HEI) stock, with an...
Salesforce stock target cut, Baird maintains Outperform By Investing.com
Investing.com· 4 hours agoOn Thursday, Baird adjusted its price target on shares of Salesforce.com (NYSE:CRM) to $295 from the...
Dick's Sporting Goods stock target reduced on solid performance By Investing.com
Investing.com· 1 hour agoOn Thursday, Baird, a financial services firm, adjusted its stock price target for Dick's Sporting...
Kevin Costner's Ex-wife Allegedly Planning To Marry The Actor's Former Financier Friend
TheBlast via Yahoo News· 1 day agoSuch a good moment, not just for me, but for the actors who came with me, for people who believed in...
Baird cuts nCino stock target, maintains neutral By Investing.com
Investing.com· 4 hours agoOn Thursday, Baird adjusted its stance on nCino Inc. (NASDAQ:NCNO), a cloud banking software...
Nvidia Holds Near Record Highs As Stock Split Looms; Is Nvidia A Buy Now?
Investor's Business Daily· 4 hours agoNvidia inched up to a new high on Thursday before pulling back. Nvidia's market cap is approaching...
Agilent shares face pressure with lower price target, Outperform intact By Investing.com
Investing.com· 4 hours agoThursday, Baird adjusted its outlook on Agilent Technologies Inc. (NYSE:A), a provider of...
Baird raises Cencora share price target citing five-year forecasts By Investing.com
Investing.com· 1 day agoOn Wednesday, Baird, a global financial services firm, adjusted its share price target for Cencora...
Baird predicts steady growth for SAGE Therapeutics at $15 target By Investing.com
Investing.com· 1 day agoBaird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a...
Baird initiates Sage Therapeutics stock with $15 PT following Zurzuvae launch By Investing.com
Investing.com· 1 day agoBaird has initiated coverage on Sage Therapeutics (NASDAQ:SAGE) with a Neutral rating and a price...